Marsh McLennan Delivers Strong Q3 Results and Announces Brand Shift to Marsh for 2026
Double-Digit Growth in Key Financial Metrics Highlights Operational Momentum
Marsh McLennan’s third-quarter 2025 results reveal a company in growth mode. Consolidated revenue climbed to $6.35 billion—an 11% increase over last year—while underlying revenue, which adjusts for currency impacts and one-offs, grew by 4%. Adjusted operating income reached $1.44 billion, up 13% year-over-year. Adjusted earnings per share rose to $1.85, an 11% increase from the previous third quarter.
For the nine months ending September 30, 2025, revenue stood at $20.39 billion, also up 11% on a GAAP basis (4% underlying), and adjusted operating income grew 11% to $5.73 billion. Net income for the quarter totaled $747 million, with a GAAP EPS of $1.51.
| Key Metric | Q3 2025 | Q3 2024 | % Change |
|---|---|---|---|
| Revenue ($M) | 6,351 | 5,697 | +11% |
| Operating Income ($M) | 1,170 | 1,108 | +6% |
| Adjusted Operating Income ($M) | 1,439 | 1,276 | +13% |
| GAAP EPS | 1.51 | 1.51 | 0% |
| Adjusted EPS | 1.85 | 1.66 | +11% |
Segment Results Reflect Consistent Gains, Especially in Risk & Insurance Services
The Risk & Insurance Services division remained a driver of growth, with Q3 revenue up 13% to $3.91 billion (3% underlying). Adjusted operating income for the segment advanced 13% to $965 million, while Marsh, its flagship unit, saw revenue surge 16% (4% underlying). Regional highlights include underlying revenue gains of 3% in the U.S. and Canada and up to 6% in Asia Pacific.
Consulting performed solidly, too. Q3 revenue grew 9% (5% underlying), with adjusted operating income up 11% to $545 million. Mercer’s business posted underlying gains in its health and wealth arms, while Oliver Wyman Group notched an 8% underlying revenue increase for the quarter.
| Segment | Q3 2025 Revenue ($M) | Underlying Revenue Growth |
|---|---|---|
| Risk & Insurance Services | 3,907 | +3% |
| Marsh | 3,400 | +4% |
| Consulting | 2,465 | +5% |
| Mercer Health | 555 | +6% |
| Mercer Wealth | 705 | +3% |
| Oliver Wyman Group | 886 | +8% |
Capital Returns and Operational Changes Highlight Commitment to Efficiency
The company continued its capital returns, repurchasing 1.9 million shares for $400 million in the third quarter and 4.6 million shares year-to-date. Notably, Marsh McLennan announced it will consolidate its businesses under the Marsh brand beginning in 2026, a move designed to boost client impact, efficiency, and leverage investments in technology, data, and analytics. The Business and Client Services (BCS) unit will serve as a focal point for innovation and operational improvement.
Investors should note the upcoming NYSE ticker symbol change from MMC to MRSH, scheduled for January 2026.
Financial Health and Balance Sheet Remain Robust
As of September 30, 2025, Marsh McLennan reported $2.51 billion in cash and cash equivalents, with total assets at $58.78 billion. The company’s equity stood at $15.36 billion, providing ample flexibility for future investments and shareholder returns.
Looking Forward: Aims to Build on Strength with Brand Realignment and Strategic Initiatives
With a solid track record of growth across its segments and a major brand transformation on the horizon, Marsh McLennan is positioning itself for the next chapter in its 2026 transition to Marsh. Management emphasized continued investments in data, AI, and operational efficiency, all geared toward delivering more value to clients and sustaining the firm’s momentum in a complex, evolving environment.
For those tracking Marsh McLennan, the key points are double-digit adjusted income and EPS growth, an aggressive rebranding initiative, and ongoing focus on innovation and capital allocation. The coming year will test whether the integration under one brand and the strategic use of technology will continue to power growth.
Contact Information:
If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.
About the Publisher - Marketchameleon.com:
Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.
NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.
The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.
Disclosure: This article was generated with the assistance of AI